Skip to main content

Table 3 Results (multiple detections not included) of multiplex real-time polymerase chain reaction assays of all included patients in order of frequency and by randomisation group (rapid vs. delayed result group)

From: Access to a polymerase chain reaction assay method targeting 13 respiratory viruses can reduce antibiotics: a randomised, controlled trial

Detected pathogens

All patients, n(%)

Rapid result group, n(%)

Delayed result group, n(%)

Influenza A virus

56 (13.8)

31 (15.3)

25 (12.3)

Rhinovirus

40 (9.9)

24 (11.9)

16 (7.8)

Coronavirus (all subtypes)

29 (7.1)

11 (5.4)

18 (8.8)

   Coronavirus OC43

16 (3.9)

4 (2.0)

12 (5.9)

   Coronavirus NL63

11 (2.7)

5 (2.5)

6 (2.9)

   Coronavirus 229E

2 (0.5)

2 (1.0)

-

Respiratory syncytial virus

18 (4.4)

6 (3.0)

12 (5.9)

Influenza B virus

14 (3.4)

7 (3.5)

7 (3.4)

Metapneumovirus

14 (3.4)

6 (3.0)

8 (3.9)

Parainfluenzavirus types 1 through 3

7 (1.7)

4 (2.0)

3 (1.5)

Mycoplasma pneumoniae

7 (1.7)

5 (2.5)

2 (1.0)

Adenovirus

4 (1.0)

2 (1.0)

2 (1.0)

Enterovirus

1 (0.2)

-

1 (0.5)

Chlamydophila pneumoniae

1 (0.2)

1 (0.5)

-

No pathogen found

215 (53.0)

105 (52.0)

110 (54)

Total, N (%)

406 (100)

202 (100)

204 (100)